Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer

被引：0
|
作者：
Francesco Boccardo
机构：
[1] Biology and Genetics at the University of Genoa,F Boccardo is Professor of Medical Oncology and Chairman of the Department of Oncology
[2] and Director of the Academic Unit of Medical Oncology (Medical Oncology B) at the National Cancer Research Institute of Genoa,undefined
[3] Italy.,undefined
来源：
Nature Clinical Practice Oncology | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：76 / 77
页数：1
相关论文
共 50 条
  • [11] Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with breast cancer or at high risk of developing it
    Sestak, I.
    Harvie, M.
    Howell, A.
    Forbes, J. F.
    Dowsett, M.
    Cuzick, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [12] Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
    Sestak, Ivana
    Harvie, Michelle
    Howell, Anthony
    Forbes, John F.
    Dowsett, Mitch
    Cuzick, Jack
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 727 - 734
  • [13] Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
    Ivana Sestak
    Michelle Harvie
    Anthony Howell
    John F. Forbes
    Mitch Dowsett
    Jack Cuzick
    Breast Cancer Research and Treatment, 2012, 134 : 727 - 734
  • [14] Effect of Tamoxifen or Anastrozole on Steroid Sulfatase Activity and Serum Androgen Concentrations in Postmenopausal Women with Breast Cancer
    Stanway, S. J.
    Palmieri, C.
    Stanczyk, F. Z.
    Folkerd, E. J.
    Dowsett, M.
    Ward, R.
    Coombes, R. C.
    Reed, M. J.
    Purohit, A.
    ANTICANCER RESEARCH, 2011, 31 (04) : 1367 - 1372
  • [15] Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology
    Gerber, B
    Krause, A
    Reimer, T
    Mylonas, I
    Makovitzky, J
    Kundt, G
    Janni, W
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1245 - 1250
  • [16] Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole
    Menada, Mario Valenzano
    Costantini, Sergio
    Moioli, Melita
    Bogliolo, Stefano
    Papadia, Andrea
    Ferrero, Simone
    Dugnani, Maria Cristina
    BREAST, 2008, 17 (06): : 631 - 636
  • [17] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial
    Boccardo, F
    Rubagotti, A
    Puntoni, M
    Guglielmini, P
    Amoroso, D
    Fini, A
    Paladini, G
    Mesiti, M
    Romeo, D
    Rinaldini, M
    Scali, S
    Porpiglia, M
    Benedetto, C
    Restuccia, N
    Buzzi, F
    Franchi, R
    Massidda, B
    Distante, V
    Amadori, D
    Sismondi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5138 - 5147
  • [18] Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women:: survival analysis and updated safety results
    Nabholtz, JM
    Bonneterre, J
    Buzdar, A
    Robertson, JFR
    Thürlimann, B
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) : 1684 - 1689
  • [19] 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview
    Buzdar, AU
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 399 - 403
  • [20] Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer
    Carraway, H
    Wolff, AC
    CANCER TREATMENT REVIEWS, 2004, 30 (03) : 303 - 307
12345